GliaSite brachytherapy for treatment of recurrent malignant gliomas: a retrospective multi-institutional analysis. - Wikidata - awgldk - TriplyDB

GliaSite brachytherapy for treatment of recurrent malignant gliomas: a retrospective multi-institutional analysis.

GliaSite brachytherapy for treatment of recurrent malignant gliomas: a retrospective multi-institutional analysis.

http://www.wikidata.org/entity/Q31035468

about

MicroRNA-222 promotes tumorigenesis via targeting DKK2 and activating the Wnt/β-catenin signaling pathway Radiotherapeutic alternatives for previously irradiated recurrent gliomas.Cerebral radiation necrosis.miR-106a-5p inhibits the proliferation and migration of astrocytoma cells and promotes apoptosis by targeting FASTK Tubeimoside-1 induces glioma apoptosis through regulation of Bax/Bcl-2 and the ROS/Cytochrome C/Caspase-3 pathway MiR-181b-5p downregulates NOVA1 to suppress proliferation, migration and invasion and promote apoptosis in astrocytoma.The Use of Three Long Non-Coding RNAs as Potential Prognostic Indicators of Astrocytoma.Identification of 9 serum microRNAs as potential noninvasive biomarkers of human astrocytoma.Antitenascin-C monoclonal antibody radioimmunotherapy for malignant glioma patients.Palliative treatment of poor prognosis patients with malignant gliomas.MicroRNA-124-3p regulates cell proliferation, invasion, apoptosis, and bioenergetics by targeting PIM1 in astrocytoma.Use of antibodies and immunoconjugates for the therapy of more accessible cancers.'Recurrent' glioblastoma multiforme, when should we reoperate?Feasibility and safety of outpatient brachytherapy in 37 patients with brain tumors using the GliaSite Radiation Therapy System.Re-irradiation alternatives for recurrent high-grade glioma.Outcome of Adult Brain Tumor Consortium (ABTC) prospective dose-finding trials of I-125 balloon brachytherapy in high-grade gliomas: challenges in clinical trial design and technology development when MRI treatment effect and recurrence appear simil Current available therapies and future directions in the treatment of malignant gliomas.Long-term survival after gamma knife radiosurgery in a case of recurrent glioblastoma multiforme: a case report and review of the literature.Increasing frequency of reirradiation studies in radiation oncology: systematic review of highly cited articles.A Review of the Role of Re-Irradiation in Recurrent High-Grade Glioma (HGG).Current trends in glioblastoma multiforme treatment: radiation therapy and immune checkpoint inhibitors Emerging insights into barriers to effective brain tumor therapeutics.Clinical trials in neurosurgical oncology.miR-137 acts as a tumor suppressor in astrocytoma by targeting RASGRF1.The role of brachytherapy in the treatment of glioblastoma multiforme.Downregulation of miR-383 promotes glioma cell invasion by targeting insulin-like growth factor 1 receptor.Knockdown of stomatin-like protein 2 (STOML2) reduces the invasive ability of glioma cells through inhibition of the NF-κB/MMP-9 pathway.MiR-136 promotes apoptosis of glioma cells by targeting AEG-1 and Bcl-2.Overexpression of SMC4 activates TGFβ/Smad signaling and promotes aggressive phenotype in glioma cells.Radiation therapy for the treatment of recurrent glioblastoma: an overview.Immediate post-operative brachytherapy prior to irradiation and temozolomide for newly diagnosed glioblastoma.Adjuvant stereotactic fractionated radiotherapy to the resection cavity in recurrent glioblastoma - the GlioCave study (NOA 17 - ARO 2016/3 - DKTK ROG trial).Radiotherapy and Glioma Stem Cells: Searching for Chinks in Cellular Armor.Elevated levels of p-Mnk1, p-eIF4E and p-p70S6K proteins are associated with tumor recurrence and poor prognosis in astrocytomas.The Clinical Utility of Matrix Metalloproteinase 9 in Evaluating Pathological Grade and Prognosis of Glioma Patients: A Meta-Analysis.Increased expression of matrix metalloproteinase-13 in glioma is associated with poor overall survival of patients.Image guidance in malignant gliomas: a focused strategy.Matrix metalloproteinase-9 expression is increased in astrocytic glioma and associated with prognosis of patients.

P2860

Q28115534-557DEC1E-0A1A-440E-8C93-55C79AFB5008 Q30497184-EB9C5EA9-CC84-4A91-BA6E-4309D6C85927 Q30686634-E1AF8BE3-961D-4665-9026-D89A45D841CA Q34980918-69228B55-D225-4E06-8A94-2BCB9136930B Q35063757-49108F03-C772-486F-B82F-CF6D095AA8E2 Q35315559-EBB42923-118C-4959-BBCC-25A217009A34 Q35739881-824ED9DB-4DDA-4BFB-A730-9A2CA16E1E67 Q35788900-7052874E-3B5A-4148-9248-3A66FE416718 Q36817119-287ED938-287D-4F4A-AB9B-57A9E4622754 Q37038922-45D06D9F-11E1-46AC-B5D8-1968FD826B60 Q37098282-48516039-9FE0-40D3-9C2F-4BC8D4990C14 Q37174938-77410A6B-E50F-4958-8697-A1E637C17743 Q37196387-7D965FDB-86E0-4E81-87D2-96C974B0DC15 Q37242114-A5DE012C-FDDC-4C79-933A-3FE8AA6825B3 Q37289558-7DC9C6B7-F3BA-4847-BC07-87AB04789E7C Q37296685-9A0FBB96-E13B-4A8B-B489-A150BC939697 Q37586907-DCF95324-A227-47FA-AF09-F8540DF0C643 Q38006702-512EB3C3-1836-4CDF-90AB-78499115E0AE Q38099657-66E1F198-B5F8-4D85-8CC1-0CCA12903955 Q38161380-E6117790-4F6B-4AD0-A837-EA4164C9C263 Q38218134-2428435A-2749-46B8-A99C-CFEFC9B5C135 Q38237653-AE850859-7BF2-419E-82BD-8343A03B18FB Q38238267-84778717-0A32-4835-B820-D5622B15A193 Q38830047-A0C66187-6A85-4CCC-BED2-6109E7D41A1C Q38834847-91916982-B862-42F4-88E1-85E4D70A5B47 Q39169837-EA75827C-9D83-4F7C-A915-66323A7FCF8D Q39465501-102955B8-3642-4E8A-A417-ECE537BCF887 Q39613855-805C7B75-7F12-45A4-B579-7C3D3AB941FD Q41981606-18A554DE-5B53-4FE4-AEDF-63FD7DE47E22 Q43089947-8A8543D9-ED22-4250-9D1B-BFA3A03D1470 Q46857246-CB25D7DC-E791-47F2-A52D-A01D68B3FF71 Q47162145-DC2F26A2-9535-4DB4-AC41-5BA5EE852E76 Q47849042-D3E1ACA8-3B5E-46EC-9284-9DC12DD0EE0F Q48412304-4E106CE8-EFED-499F-90C8-AB14016EED08 Q48613068-C87B9BA9-1E17-4F77-AC55-DE5137F9FF2F Q48650439-C591F9AD-3537-4125-9F08-9498415D8723 Q55461902-3CF0864A-D13E-45BE-84B8-0AE8CF281375 Q55461963-211220C0-3790-4999-A496-E7DA0143877C

P2860

GliaSite brachytherapy for treatment of recurrent malignant gliomas: a retrospective multi-institutional analysis.

http://www.wikidata.org/entity/Q31035468

description

2006 nî lūn-bûn

@nan

2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

GliaSite brachytherapy for tre ...... multi-institutional analysis.

@ast

GliaSite brachytherapy for tre ...... multi-institutional analysis.

@en

type

label

GliaSite brachytherapy for tre ...... multi-institutional analysis.

@ast

GliaSite brachytherapy for tre ...... multi-institutional analysis.

@en

prefLabel

GliaSite brachytherapy for tre ...... multi-institutional analysis.

@ast

GliaSite brachytherapy for tre ...... multi-institutional analysis.

@en

P1433

Q31035468-223F5251-78E0-426C-8661-21FCDEF3FBF3

P1476

Q31035468-638389BF-7ECE-495F-B266-FAB79EEE3898

P2093

Q31035468-1133F8FE-13EC-4A69-9A60-0121E7FD6536

Q31035468-4EFD6C5F-73D7-4129-A8A6-9D8B7A69D2CA

Q31035468-5795025A-2D41-409F-A1AB-82E940C6C2C4

Q31035468-7184F74D-85DA-4194-87CB-291E5044024C

Q31035468-72D94B35-0436-4C08-BD77-D02B7F3D5B4C

Q31035468-739B8F97-E948-435D-8387-770D89E09EB6

Q31035468-78A13CC6-E092-4650-8B53-F233D030CA29

Q31035468-8FEE045B-8AFE-49FF-ACE6-09311E077BE4

Q31035468-905A6073-2D71-405B-BC6A-DA281ACEA6C2

Q31035468-BCBCCBDD-6744-4989-B11A-66CE670AA2FD

P2860

Q31035468-0B07A694-C084-4FA0-AB6D-C75072F22823

Q31035468-0DF47B2C-8DF5-4FAC-8DFA-2AA3B4F0CCDF

Q31035468-1A99692A-285D-48F0-9AFE-972C4A08EF60

Q31035468-1C5CC7C7-47C5-4472-96E7-2C3978891CFF

Q31035468-46E8F603-1585-4BE1-BDD0-FB97204FF708

Q31035468-7134A2DE-EB1F-4B2D-A56B-8BE230EE8C0B

Q31035468-8F915184-F700-433E-AAC5-E1C1BB067BC4

Q31035468-8FD722E3-17E2-4816-9913-EECA529DB393

Q31035468-91A8EB31-704A-411F-B995-0BC16F030979

Q31035468-A2B6511E-2181-42F7-A509-8EFF3253C0B0

P304

Q31035468-8D4812D5-783A-4358-A92C-4DE99E9E65B3

P31

Q31035468-1743FA07-F6A2-4CD0-B2D2-3DCDA7534520

P356

Q31035468-42B4D96C-93DA-43DB-BE90-CD547E91D8BD

P407

Q31035468-1571C735-75B4-41A5-B41C-3C89BBA7B141

P433

Q31035468-02CB959B-24BF-4AC2-AFE1-8BEAEA725158

P478

Q31035468-00796994-639E-4FC6-8A08-50394BABF024

P577

Q31035468-A3809BCE-462B-4F2C-87C9-20B649B1009E

P5875

Q31035468-E3633AC0-0FDE-497E-BA2D-D7C41BAEBF26

P698

Q31035468-15ADAFFD-DE50-4458-9307-A5E3F1DB9FC4

P921

Q31035468-58A1EBA1-9F3E-4245-9062-E846ADFF6162

Q31035468-F1B6C562-3CB5-4C18-AE40-699363A3475D

P356

01.NEU.0000194836.07848.69

P1433

P1476

GliaSite brachytherapy for tre ...... multi-institutional analysis.

@en

P2093

Abhay Sanan

http://www.w3.org/2001/XMLSchema#string

Arash J Gabayan

http://www.w3.org/2001/XMLSchema#string

Ashish Patel

http://www.w3.org/2001/XMLSchema#string

Baldassarre Stea

http://www.w3.org/2001/XMLSchema#string

Christopher Schultz

http://www.w3.org/2001/XMLSchema#string

Gordon Watson

http://www.w3.org/2001/XMLSchema#string

Joseph Jenrette

http://www.w3.org/2001/XMLSchema#string

Kenneth T Bastin

http://www.w3.org/2001/XMLSchema#string

Michael Papagikos

http://www.w3.org/2001/XMLSchema#string

Pradip Amin

http://www.w3.org/2001/XMLSchema#string

P2860

Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery.

Interstitial irradiation of brain tumors: a review.

Permanent 125iodine implants for recurrent malignant gliomas.

On the development of an interstitial radiation protocol for a multicenter consortium. Experience with permanent low-dose rate and temporary high-dose rate 125I implants in 'failed' and 'newly diagnosed' glioblastoma patients: quality assurance meth

Interstitial radiogold implantation for the treatment of recurrent high-grade gliomas.

Stereotactic radiosurgery for recurrent gliomas.

Demonstration of brachytherapy boost dose-response relationships in glioblastoma multiforme.

Survival and quality of life after interstitial implantation of removable high-activity iodine-125 sources for the treatment of patients with recurrent malignant gliomas.

Use of the RTOG recursive partitioning analysis to validate the benefit of iodine-125 implants in the primary treatment of malignant gliomas.

Long term results of stereotactic brachytherapy used in the initial treatment of patients with glioblastomas.

P304

701-9; discussion 701-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1227/01.NEU.0000194836.07848.69

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

58

http://www.w3.org/2001/XMLSchema#string

P577

2006-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7204882

http://www.w3.org/2001/XMLSchema#string

P698

16575334

http://www.w3.org/2001/XMLSchema#string

P921